T. Fojo

Oncology · 2002–2018

A researcher in the Science corpus: 6 papers; trusts 1 researcher and is trusted by 1 researcher here, as inferred from the citation graph.

Subfields

Whom T. Fojo trusts overall

Their strongest outbound trust, strongest first, inferred from their citations.

  1. Rakesh K. Jain

Who trusts T. Fojo overall

  1. Piyush B. Gupta
  2. N. Frank

Papers from T. Fojo's perspective

Ordered by how strongly the researchers T. Fojo trusts endorse each paper. Same corpus, a different order for every researcher.

  1. Stem cells, cancer, and cancer stem cells (Nature)
  2. Role of breast cancer resistance protein in the bioavailability and fetal penetration of topotecan. (Journal of the National Cancer Institute)
  3. Acute myeloid leukemia originates from a hierarchy of leukemic stem cell classes that differ in self-renewal capacity (Nature Immunology)
  4. Role of tumor–host interactions in interstitial diffusion of macromolecules: Cranial vs. subcutaneous tumors (Proceedings of the National Academy of Sciences of the United States of America)
  5. Normalizing tumor vasculature with anti-angiogenic therapy: A new paradigm for combination therapy (Nature Medicine)
  6. Similar MLL-associated leukemias arising from self-renewing stem cells and short-lived myeloid progenitors. (Genes & Development)
  7. Subcellular localization and distribution of the breast cancer resistance protein transporter in normal human tissues. (Cancer Research)
  8. Cancerous stem cells can arise from pediatric brain tumors (Proceedings of the National Academy of Sciences of the United States of America)
  9. Clinical Resistance to STI-571 Cancer Therapy Caused by BCR-ABL Gene Mutation or Amplification (Science)
  10. Therapeutic implications of cancer stem cells. (Current Opinion in Genetics and Development)

Their papers